Development of an Anti-Endotoxin Vaccine for Sepsis
Publisher
Springer Netherlands
Reference72 articles.
1. Bahador, M., Cross, A.S. From therapy to experimental model: A hundred years of endotoxin administration to human subjects. J Endotox Res (now Innate Immunity) 13 (2007) 251–279. 2. Baker, B., Gaffin, S.L., Wells, M., Wessels, B.C., Brock-Utne, J.G. Endotoxemia in racehorses following exercise. J S Afr Vet Assoc 59 (1988) 64–66. 3. Bailat, S., Heumann, D., LeRoy, D. Baumgartner, J-D., Rietschel, E.T., Glauser, M.P., DiPadova, F., Similarities and disparities between core-specific and O-side chain specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Infect Immun 65 (1997) 811. 4. Baumgartner, J-D., Glauser, M.P., McCutchan, J.A, Ziegler, E.J., van Melle, G., Klauber, M.R., Vogt, M., Muehlen, E., Luethy, R., Chiolero, R., Preventiion of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 2 (1985) 59–63. 5. Baumgartner, J.D., Heumann, D., Calandra, T., Glauser, M.P., Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5. J Infect Dis 163 (1991) 769.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|